|
1
|
Magnano LC, Martínez Cibrian N, Andrade
González X and Bosch X: Cardiac complications of chemotherapy: role
of prevention. Curr Treat Options Cardiovasc Med. 16:3122014.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Truong J, Yan AT, Cramarossa G and Chan
KK: Chemotherapy-induced cardiotoxicity: detection, prevention, and
management. Can J Cardiol. 30:869–878. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Spagnuolo RD, Recalcati S, Tacchini L and
Cairo G: Role of hypoxia-inducible factors in the
dexrazoxane-mediated protection of cardiomyocytes from
doxorubicin-induced toxicity. Br J Pharmacol. 163:299–312. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Zhang Y, Tang ZH, Ren Z, Qu SL, Liu MH,
Liu LS and Jiang ZS: Hydrogen sulfide, the next potent preventive
and therapeutic agent in aging and age-associated diseases. Mol
Cell Biol. 33:1104–1113. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Osipov RM, Robich MP, Feng J, Liu Y,
Clements RT, Glazer HP, Sodha NR, Szabo C, Bianchi C and Sellke FW:
Effect of hydrogen sulfide in a porcine model of myocardial
ischemia-reperfusion: comparison of different administration
regimens and characterization of the cellular mechanisms of
protection. J Cardiovasc Pharmacol. 54:287–297. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Huang YE, Tang ZH, Xie W, Shen XT, Liu MH,
Peng XP, Zhao ZZ, Nie DB, Liu LS and Jiang ZS: Endogenous hydrogen
sulfide mediates the cardioprotection induced by ischemic
post-conditioning in the early reperfusion phase. Exp Ther Med.
4:1117–1123. 2012.PubMed/NCBI
|
|
7
|
Wang H, Zhou X, Huang J, Mu N, Guo Z, Wen
Q, Wang R, Chen S, Feng ZP and Zheng W: The role of Akt/FoxO3a in
the protective effect of venlafaxine against corticosterone-induced
cell death in PC12 cells. Psychopharmacology (Berl). 228:129–141.
2013. View Article : Google Scholar
|
|
8
|
van der Vos KE and Coffer PJ: The
extending network of FOXO transcriptional target genes. Antioxid
Redox Signal. 14:579–592. 2011. View Article : Google Scholar
|
|
9
|
Sanphui P and Biswas SC: FoxO3a is
activated and executes neuron death via Bim in response to
β-amyloid. Cell Death Dis. 4:e6252013. View Article : Google Scholar
|
|
10
|
Bao W, Pan F, Chen L, Su G, Gao X, Li Y,
Sun Q, Sun J, He K and Song H: The PI3K/AKT pathway and FOXO3a
transcription factor mediate high glucose-induced apoptosis in
neonatal rat ventricular myocytes. Iran Red Crescent Med J.
16:e149142014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Li D, Qu Y, Mao M, Zhang X, Li J, Ferriero
D and Mu D: Involvement of the PTEN-AKT-FOXO3a pathway in neuronal
apoptosis in developing rat brain after hypoxia-ischemia. J Cereb
Blood Flow Metab. 29:1903–1913. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Liu MH, Yuan C, He J, Tan TP, Wu SJ, Fu
HY, Liu J, Yu S, Chen YD, Le QF, et al: Resveratrol protects PC12
cells from high glucose-induced neurotoxicity via PI3K/Akt/FoxO3a
pathway. Cell Mol Neurobiol. 35:513–522. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhang MQ, Zheng YL, Chen H, Tu JF, Shen Y,
Guo JP, Yang XH, Yuan SR, Chen LZ, Chai JJ, et al: Sodium
tanshinone IIA sulfonate protects rat myocardium against
ischemia-reperfusion injury via activation of PI3K/Akt/FOXO3A/Bim
pathway. Acta Pharmacol Sin. 34:1386–1396. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Juhasz B, Thirunavukkarasu M, Pant R, Zhan
L, Penumathsa SV, Secor ER Jr, Srivastava S, Raychaudhuri U, Menon
VP, Otani H, et al: Bromelain induces cardioprotection against
ischemia-reperfusion injury through Akt/FOXO pathway in rat
myocardium. Am J Physiol Heart Circ Physiol. 294:H1365–H1370. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Guo R, Wu K, Chen J, Mo L, Hua X, Zheng D,
Chen P, Chen G, Xu W and Feng J: Exogenous hydrogen sulfide
protects against doxorubicin-induced inflammation and cytotoxicity
by inhibiting p38MAPK/NFκB pathway in H9c2 cardiac cells. Cell
Physiol Biochem. 32:1668–1680. 2013.
|
|
16
|
Tocchetti CG, Carpi A, Coppola C,
Quintavalle C, Rea D, Campesan M, Arcari A, Piscopo G, Cipresso C,
Monti MG, et al: Ranolazine protects from doxorubicin-induced
oxidative stress and cardiac dysfunction. Eur J Heart Fail.
16:358–366. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wang XY, Yang CT, Zheng DD, Mo LQ, Lan AP,
Yang ZL, Hu F, Chen PX, Liao XX and Feng JQ: Hydrogen sulfide
protects H9c2 cells against doxorubicin-induced cardiotoxicity
through inhibition of endoplasmic reticulum stress. Mol Cell
Biochem. 363:419–426. 2012. View Article : Google Scholar
|
|
18
|
Su YW, Liang C, Jin HF, Tang XY, Han W,
Chai LJ, Zhang CY, Geng B, Tang CS and Du JB: Hydrogen sulfide
regulates cardiac function and structure in adriamycin-induced
cardiomyopathy. Circ J. 73:741–749. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kim KH, Oudit GY and Backx PH:
Erythropoietin protects against doxorubicin-induced cardiomyopathy
via a phosphatidylinositol 3-kinase-dependent pathway. J Pharmacol
Exp Ther. 324:160–169. 2008. View Article : Google Scholar
|
|
20
|
An T, Zhang Y, Huang Y, Zhang R, Yin S,
Guo X, Wang Y, Zou C, Wei B, Lv R, et al: Neuregulin-1 protects
against doxorubicin-induced apoptosis in cardiomyocytes through an
Akt-dependent pathway. Physiol Res. 62:379–385. 2013.PubMed/NCBI
|
|
21
|
Hong HJ, Liu JC, Chen PY, Chen JJ, Chan P
and Cheng TH: Tanshinone IIA prevents doxorubicin-induced
cardiomyocyte apoptosis through Akt-dependent pathway. Int J
Cardiol. 157:174–179. 2012. View Article : Google Scholar
|
|
22
|
Chen YL, Loh SH, Chen JJ and Tsai CS:
Urotensin II prevents cardiomyocyte apoptosis induced by
doxorubicin via Akt and ERK. Eur J Pharmacol. 680:88–94. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ho KK, McGuire VA, Koo CY, Muir KW, de
Olano N, Maifoshie E, Kelly DJ, McGovern UB, Monteiro LJ, Gomes AR,
et al: Phosphorylation of FOXO3a on Ser-7 by p38 promotes its
nuclear localization in response to doxorubicin. J Biol Chem.
287:1545–1555. 2012. View Article : Google Scholar :
|
|
24
|
Wang Y, Zhou Y and Graves DT: FOXO
transcription factors: their clinical significance and regulation.
Biomed Res Int. 2014:9253502014.PubMed/NCBI
|
|
25
|
Storz P: Forkhead homeobox type O
transcription factors in the responses to oxidative stress.
Antioxid Redox Signal. 14:593–605. 2011. View Article : Google Scholar :
|
|
26
|
Peng C, Ma J, Gao X, Tian P, Li W and
Zhang L: High glucose induced oxidative stress and apoptosis in
cardiac microvascular endothelial cells are regulated by FoxO3a.
PLoS One. 8:e797392013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhang S, Zhao Y, Xu M, Yu L, Zhao Y, Chen
J, Yuan Y, Zheng Q and Niu X: FoxO3a modulates hypoxia stress
induced oxidative stress and apoptosis in cardiac microvascular
endothelial cells. PLoS One. 8:e803422013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Pan Q, Xie X, Guo Y and Wang H:
Simvastatin promotes cardiac microvascular endothelial cells
proliferation, migration and survival by phosphorylation of p70 S6K
and FoxO3a. Cell Biol Int. 38:599–609. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Jia Y, Mo SJ, Feng QQ, Zhan ML, OuYang LS,
Chen JC, Ma YX, Wu JJ and Lei WL: EPO-dependent activation of
PI3K/Akt/FoxO3a signalling mediates neuroprotection in in vitro and
in vivo models of Parkinson's disease. J Mol Neurosci. 53:117–124.
2014. View Article : Google Scholar : PubMed/NCBI
|
